Qiagen NV - ESG Rating & Company Profile powered by AI
Other companies in the scoring peer group for Qiagen NV are shown below. If you work at Qiagen NV and you wish to licence your Sustainability aseessment, please contact us. The analysis of Qiagen NV was prepared by All Street Sevva using cutting edge NLP.
Qiagen NV in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.0; made up of an environmental score of 6.0, social score of 7.0 and governance score of 8.0.
7.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 224 | Xintela AB | 7.1 | High |
| 224 | Zelira Therapeutics Ltd | 7.1 | High |
| 290 | Qiagen NV | 7.0 | High |
| 290 | IDEXX Laboratories Inc | 7.0 | High |
| 290 | Rallybio Corp | 7.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Qiagen NV have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Qiagen NV disclose current and historical energy intensity?
Sign up for free to unlockDoes Qiagen NV report the average age of the workforce?
Sign up for free to unlockDoes Qiagen NV reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Qiagen NV disclose its ethnicity pay gap?
Sign up for free to unlockDoes Qiagen NV disclose cybersecurity risks?
Sign up for free to unlockDoes Qiagen NV offer flexible work?
Sign up for free to unlockDoes Qiagen NV have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Qiagen NV disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Qiagen NV conduct supply chain audits?
Sign up for free to unlockDoes Qiagen NV disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Qiagen NV conduct 360 degree staff reviews?
Sign up for free to unlockDoes Qiagen NV disclose the individual responsible for D&I?
Sign up for free to unlockDoes Qiagen NV disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Qiagen NV disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Qiagen NV disclose water use targets?
Sign up for free to unlockDoes Qiagen NV have careers partnerships with academic institutions?
Sign up for free to unlockDid Qiagen NV have a product recall in the last two years?
Sign up for free to unlockDoes Qiagen NV disclose incidents of discrimination?
Sign up for free to unlockDoes Qiagen NV allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Qiagen NV issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Qiagen NV disclose parental leave metrics?
Sign up for free to unlockDoes Qiagen NV disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Qiagen NV disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Qiagen NV disclose the pay ratio of women to men?
Sign up for free to unlockDoes Qiagen NV support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Qiagen NV disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Qiagen NV reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Qiagen NV involved in embryonic stem cell research?
Sign up for free to unlockDoes Qiagen NV disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Qiagen NV disclose its waste policy?
Sign up for free to unlockDoes Qiagen NV report according to TCFD requirements?
Sign up for free to unlockDoes Qiagen NV disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Qiagen NV disclose energy use targets?
Sign up for free to unlockDoes Qiagen NV disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Qiagen NV have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Qiagen NV
These potential risks are based on the size, segment and geographies of the company.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.